Exhaled nitric oxide levels in alpha-1-antitrypsin PiMZ subjects

Journal of Internal Medicine

Volumn 265, Issue 3, 2009, Pages 382-387

  Malerba, M ^a   Ragnoli, B ^a   Radaeli, A ^a  

^a UNIVERSITY OF BRESCIA   (Italy)

Author keywords

Airway inflammation; Alpha 1 antitrypsin deficiency; Exhaled nitric oxide

Indexed keywords

ALPHA 1 ANTITRYPSIN; NITRIC OXIDE;

ADULT; ALPHA 1 ANTITRYPSIN DEFICIENCY; AMBULATORY CARE; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; FEMALE; HUMAN; LUNG FUNCTION TEST; MALE; PHENOTYPE; POPULATION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL;

ADULT; AGED; ALPHA 1-ANTITRYPSIN DEFICIENCY; BREATH TESTS; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; MALE; MIDDLE AGED; NITRIC OXIDE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; VITAL CAPACITY;

EID: 60349114163     PISSN: 09546820     EISSN: 13652796     Source Type: Journal    
DOI: 10.1111/j.1365-2796.2008.02021.x     Document Type: Article

References (24)

1. Aboussuan LS, Stoller JK. New developments in alpha 1-antitrypsin deficiency. Am J Respir Crit Care Med 1999 20 : 301 10.
2. Hersh CP, Dahl M, Ly NP et al. Chronic obstructive pulmonary disease in alpha-1-antitrypsin PIMZ heterozygotes: a meta-analysis. Thorax 2004 59 : 843 9.
3. Pina JS, Horan MP. Alpha 1-antitrypsin deficiency and asthma. The continuing search for the relationship. Postgrad Med 1997 101 : 153 68.
4. Gaillard MC, Kilroe-Smith TA, Nogueira C et al. Alpha-1-protease inhibitor in bronchial asthma: phenotypes and biochemical characteristics. Am Rev Respir Dis 1992 145 : 1311 5.
5. Townley RG, Southard JG, Radford P, Hopp RJ, Bewtra AK, Ford L. Association of MS Pi phenotype with airway hyperresponsiveness. Chest 1990 98 : 594 9.
6. Hill AT, Campbell EJ, Bayley DL, Hill SL, Stockley RA. Evidence for excessive bronchial inflammation during an acute exacerbation of chronic obstructive pulmonary disease in patients with α1-antitrypsin deficiency (PiZ). Am J Respir Crit Care Med 1999 160 : 1968 75.
7. Hubbard RC, Fells G, Gadek J, Pacholok S, Humes J, Crystal RG. Neutrophil accumulation in the lung in alpha-1-antitrypsin deficiency. Spontaneous release of leukotriene B4 by alveolar macrophages. J Clin Invest 1991 88 : 891 7.
8. Malerba M, Ricciardolo F, Radaeli A et al. Neutrophilic inflammation and IL-8 levels in induced sputum of alpha-1-antitrypsin PiMZ subjects. Thorax 2006 61 : 129 33.
9. Dahl M, Tybjaerg-Hansen A, Lange P, Vestbo J, Nordestgaard BG. Change in lung function and morbidity from chronic obstructive pulmonary disease in alpha1-antitrypsin MZ heterozygotes: a longitudinal study of the general population. Ann Intern Med 2002 136 : 270 9.
10. 1-antitrypsin heterozygotes of phenotype PiMZ. Am J Respir Crit Care Med 2000 161 : 81 4.
11. Kharitonov SA, Barnes PJ. Exhaled markers of pulmonary disease. Am J Respir Crit Care Med 2001 163 : 1693 722.
12. Montuschi P, Kharitonov SA, Barnes PJ. Exhaled carbon monoxide and nitric oxide in COPD. Chest 2001 120 : 496 501.
13. Novoradovsky A, Brantly ML, Waclawiw MA et al. Endothelial nitric oxide synthase as a potential susceptibility gene in the pathogenesis of emphysema in alpha-1-anti-trypsin deficiency. Am J Respir Cell Mol Biol 1999 20 : 441 7.
14. COPD Guidelines Group of the Standards of Care Committee of the BTS. BTS guidelines for the management of chronic obstructive pulmonary disease. Thorax 1997 52 : S1 28.
15. Luisetti M, Massi G, Massobrio M et al. A national program for detection of alpha-1-antitrypsin deficiency in Italy. Respir Med 1999 93 : 169 72.
16. Massi G, Marano G, Patalano F et al. Silver-stained phenotyping alpha-1-antitrypsin in dried blood and serum specimens. Clin Chem 1984 30 : 1674 6.
17. Clausen JL, Coates AL, Quanjer PH. Measurement of lung volumes in humans: review and recommendations from an ATS/ERS workshop. Eur Respir J 1997 10 : 1205 6.
18. ATS/ERS recommendations for standardized procedures for online and offline measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide. Am J Respir Crit Care Med 2005 171 : 912 30.
19. Olivieri M, Talamini G, Corradi M et al. Reference values for exhaled nitric oxide (reveno) study. Respir Res. 2006 7 : 94.
20. Malerba M, Clini E, Radaeli A et al. Exhaled nitric oxide in patients with alfa-1 antitrypsin (AAT) deficiency. Monadi Arch Chest Dis. 2001 56 : 175 6.
21. Wang XL, Sim AS, Badenhop RF, McCredie RM, Wilcken DE. A smoking-dependent risk of coronary artery disease associated with a polymorphism of the endothelial nitric oxide synthase gene. Nat Med 1996 2 : 41 5.
22. Malerba M, Radaeli A, Ceriani L, Tantucci C, Grassi V. Airway hyperresponsiveness in a large group of subjects with akpha 1 antitrypsin deficiency: a cross sectional controlled study. J Intern Med 2003 253 : 351 8.
23. Machado RF, Stoller JK, Laskowsky D et al. Low levels of nitric oxide and carbon monoxide in α1-antitrypsin deficiency. J Appl Physiol 2002 93 : 2038 43.
24. Malerba M, Clini E, Cremona G et al. Exhaled nitric oxide in patients with PiZZ phenotype-related alfa-1 antitrypsin deficiency. Respir Med 2001 95 : 520 5.